Literature DB >> 11754969

Adrenomedullin in the cerebral circulation.

B Kis1, C S Abrahám, M A Deli, H Kobayashi, A Wada, M Niwa, H Yamashita, Y Ueta.   

Abstract

The central nervous system requires an effective autoregulation of cerebral circulation in order to meet the critical and unusual demands of the brain. In addition, cerebral microvessels has a unique feature, the formation of the blood-brain barrier, which contributes to the stability of the brain parenchymal microenvironment. Many factors are known to be involved in the regulation of cerebral circulation and blood-brain barrier functions. In the last few years a new potential candidate, adrenomedullin, a hypotensive peptide was added to this list. Adrenomedullin has a potent vasodilator effect on the cerebral vasculature, and it may be implicated in the pathologic mechanism of cerebrovascular diseases. In this review, we describe current knowledge about the origin and possible role of adrenomedullin in the regulation of cerebral circulation and blood-brain barrier functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754969     DOI: 10.1016/s0196-9781(01)00533-2

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

1.  Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5.

Authors:  Masaru Honda; Shinsuke Nakagawa; Kentaro Hayashi; Naoki Kitagawa; Keisuke Tsutsumi; Izumi Nagata; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2006-04-20       Impact factor: 5.046

2.  HIF-1alpha subunit and vasoactive HIF-1-dependent genes are involved in carbon monoxide-induced cerebral hypoxic stress response.

Authors:  S Bani Hashemi; J Braun; W M Bernhardt; W Rascher; J Dötsch; R Trollmann
Journal:  Eur J Appl Physiol       Date:  2008-06-17       Impact factor: 3.078

3.  Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.

Authors:  Yanli Zhu; Lihong Zhang; Jeffrey M Gidday
Journal:  J Ocul Pharmacol Ther       Date:  2008-12       Impact factor: 2.671

Review 4.  Adrenomedullin, a Novel Target for Neurodegenerative Diseases.

Authors:  Hilda Ferrero; Ignacio M Larrayoz; Francisco J Gil-Bea; Alfredo Martínez; María J Ramírez
Journal:  Mol Neurobiol       Date:  2018-03-29       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.